SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-20-290930
Filing Date
2020-11-12
Accepted
2020-11-12 06:11:09
Documents
49
Period of Report
2020-11-12

Document Format Files

Seq Description Document Type Size
1 6-K d55667d6k.htm 6-K 14662
2 EX-99.1 d55667dex991.htm EX-99.1 236189
3 EX-99.2 d55667dex992.htm EX-99.2 121744
4 EX-99.3 d55667dex993.htm EX-99.3 98259
11 GRAPHIC g55667g55y57.jpg GRAPHIC 4138
12 GRAPHIC g55667g89j19.jpg GRAPHIC 51187
  Complete submission text file 0001193125-20-290930.txt   2451092

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT asnd-20200930.xml EX-101.INS 433612
6 XBRL TAXONOMY EXTENSION SCHEMA asnd-20200930.xsd EX-101.SCH 31960
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE asnd-20200930_cal.xml EX-101.CAL 33885
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE asnd-20200930_def.xml EX-101.DEF 84908
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE asnd-20200930_lab.xml EX-101.LAB 212890
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asnd-20200930_pre.xml EX-101.PRE 160757
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 201303025
SIC: 2834 Pharmaceutical Preparations